Oral Cavity Carcinoma — Trials

Oral Cavity Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

310 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 43
Ph III recruiting: 9
Growth YoY: +13.6%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05316688	A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery	terminated	Phase 1 / Phase 2	8	University of WashingtonOTHER	1	Sep 16, 2026	clinicaltrials
NCT03799445	Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma	terminated	Phase 2	37	M.D. Anderson Cancer CenterOTHER	1	Apr 30, 2026